2011
DOI: 10.1142/s0192415x11008658
|View full text |Cite
|
Sign up to set email alerts
|

Antioxidant Activities of Dracocephalum tanguticum Maxim Extract and Its Up-Regulation on the Expression of Neurotrophic Factors in a Rat Model of Permanent Focal Cerebral Ischemia

Abstract: The aim of this study was to investigate the effect of a BuOH-soluble fraction from Dracocephalum tanguticum Maxim (DME), which contained 52% of total flavonoid, on the cerebral ischemia injury induced by permanent middle cerebral artery occlusion (pMCAO) in rats. RT-PCR and Western blot analysis showed that DME (30 mg/kg/day for seven days) by intragastric administration modulated the mRNA expression and protein synthesis of two neurotrophic factors: brain-derived neurotrophic factor (BDNF) and neurotrophin 3… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
8
0

Year Published

2011
2011
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 38 publications
0
8
0
Order By: Relevance
“…In addition, there is consistent report that a catechol group is related to antioxidant capacity (Cai et al, 2006). There are some reports showing antioxidant effects via antioxidant enzymes (Chiang et al, 2006; Sahin et al, 2010; Xu et al, 2011). In our previous report, baicalein induced Mn SOD via the activation of Nrf2 transcription factor; this resulted in the protection of mitochondria against oxidative stress (Lee et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…In addition, there is consistent report that a catechol group is related to antioxidant capacity (Cai et al, 2006). There are some reports showing antioxidant effects via antioxidant enzymes (Chiang et al, 2006; Sahin et al, 2010; Xu et al, 2011). In our previous report, baicalein induced Mn SOD via the activation of Nrf2 transcription factor; this resulted in the protection of mitochondria against oxidative stress (Lee et al, 2011).…”
Section: Discussionmentioning
confidence: 99%
“…In this regard, animal studies have demonstrated neuroprotective effects of: (1) infusion of BDNF into the brain (Beck et al, 1994; Novikova et al, 2000; Nomura et al, 2005); (2) viral vector-mediated delivery of the BDNF gene into neurons (Bemelmans et al, 2006; Nosheny et al, 2007; Nagahara et al, 2009); (3) transplantation of cells genetically engineered to overexpress BDNF (Frim et al, 1994; Liu et al, 1999; Nomura et al, 2005); (4) administration of chemicals that stimulate neurons to produce BDNF (Hou et al, 2010; Xu et al, 2011; Fass et al, 2012); and (5) treatment with chemicals that activate trkB (Lee and Chao, 2001; Massa et al, 2010; Devi and Ohno, 2012; Schmid et al, 2012). Drugs in one class of widely prescribed anti-depressants, the serotonin- and norepinephrine reuptake inhibitors, are believed to exert their clinical benefit by up-regulating BDNF production (Xu et al, 2003, 2006; De Foubert et al, 2004; Russo-Neustadt et al, 2004; Yoshimura et al, 2007).…”
Section: Potential Therapeutic Interventions To Sustain Restore and mentioning
confidence: 99%
“…It has been shown that developmental exposure to toluene,(Win-Shwe et al ., 2010) lead,(Chao et al ., 2007) and infectious agents (Pang et al ., 2010) increased biomarkers of oxidative stress and neuroinflammation that were associated with decreased expression of neurotrophins in regions of the brain including the hippocampus. Along this line, NGF has been shown to upregulate glutathione synthesis in mice,(Arsenijevic et al ., 2007) and antioxidant therapy increased the expression of BDNF in hippocampus (Xu et al ., 2011; Moriya et al ., 2011; Liu et al ., 2009). In disorders of the CNS such as autism, oxidative stress appears inextricably linked to the loss of neurotrophic support (Sajdel-Sulkowska et al ., 2009; Sajdel-Sulkowska et al ., 2011a).…”
Section: Introductionmentioning
confidence: 99%